Webinar: Injecting Neural Stem Cells into ALS Patients: Results of a Phase 1 Trial | Jonathan Glass

Title: Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS:  Results of a Phase I Trial in 12 Patients
Speaker: Jonathan D. Glass, M.D.
Professor, Neurology and Pathology, Emory University School of Medicine

Presented April 15, 2013

This presentation was part of the webinar event, "Clinical Trials: Moving Stem Cell based Therapies to the Clinic - Presentations from FDA and Leading Experts" hosted by CIRM and the Regenerative Medicine Consortium

The focus of this webinar is on the Lessons Learned from IND/Phase I trials including overcoming the challenges, and addressing the regulatory issues, as stem cell based therapies move towards the clinic.

To learn more about CIRM-funded progress toward therapies, click here.

© 2013 California Institute for Regenerative Medicine